Biotech - Technical Analysis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech - Technical Analysis

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (301)	4/8/2002 4:30:28 PM
From: Jibacoa	Read Replies (1) of 544

ICN Is rebounding some today after the article on Barron's about the IPO of Ribapharm.<g> siliconinvestor.com Although none of the money from the IPO will go to ICN, they still will control 80% of Ribapharm stock after the IPO.<g> And it is possible that some time in the future ICN will spin off Ribapharm stock to its shareholders in a "tax free transfer".<g> And of course Ribapharm stock should do well in spite of its declining revenues and earnings, not only because UBS Warburg has a good record on its recent IPOs (up about 18%)but also since Milan Panic is going to have 5 million options exercisable at the IPO price.<g> And since he is 71 years old and the shareholders of ICN want to have him out, it seems fair that he should have some consolation. ( I am somewhat biased for people in his age group.<g) Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next